Innate Pharma Ratios (2017-2025) | IPHA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Dec2017	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025
Profitability
EBT Margin				-22.88%	-88.40%			-342.48%		-0.12%	1.61%	-11.05%	-292.40%	-360.45%	-807.14%
EBIT Margin				-30.10%	-188.40%			-375.48%		-0.12%	-1.13%	-14.59%	-317.29%	-391.94%	-907.14%
EBITDA Margin				-30.10%	-188.40%			-375.48%		-0.12%	-1.13%	-14.59%	-317.29%	-391.94%	-907.14%
Operating Margin				-30.10%	-188.40%			-375.48%		-0.12%	-1.13%	-14.59%	-317.29%	-391.94%	-907.14%
Net Margin				-338.10%	-4,777.27%	-390.23%		-947.58%	-0.42%	-0.11%	1.61%	-111.05%	-292.40%	-430.44%	-807.14%
FCF Margin				1.84%	-1,297.25%	-90.57%		-474.97%	2.41%	-0.04%	-31.56%	-62.06%		-51.54%
Efficiency
Assets Average		0.41B			166.76B	166.72B	0.34B	0.31B	0.30B	0.26B	0.21B	0.20B	0.18B	0.14B	0.11B
Equity Average		0.15B
Invested Capital	0.11B	0.20B	0.02B	0.26B	2.04B	0.02B	0.00B	0.05B	0.03B	0.04B	0.01B	0.04B	0.01B	0.03B	0.01B
Asset Utilization Ratio					0.00	0.00	0.43	0.27	0.06	198.18	236.16	250.18	288.29	0.83	0.73
Leverage & Solvency
Interest Coverage Ratio				4.17	1.88			11.38		0.00B	0.41	4.13	12.75	12.45	9.07
Debt to Equity	0.07	0.03		0.09
Debt Ratio	0.02	0.01		0.05	0.06	0.06	0.06	0.17	0.15	0.20	0.20	0.23	0.23	0.28	0.29
Equity Ratio	0.34	0.37		0.54
Times Interest Earned				4.17	1.88			11.38		0.00B	0.41	4.13	12.75	12.45	9.07
Valuation
Enterprise Value	-0.14B	-0.19B	-0.17B	-0.24B	-147.74B	-0.18B	-0.18B	-0.14B	-0.13B	-0.10B	-0.11B	-0.10B	-0.10B	-0.09B	-0.08B
Return Ratios
Return on Sales				-0.23%	-0.88%	-1.12%	-0.60%	-0.61%	0.00%	0.00%	0.02%	-0.11%	-2.92%	-3.60%	-8.07%
Return on Capital Employed								-0.35%		-0.53%	-0.60%	-0.75%	-0.71%	-0.85%	-1.50%
Return on Assets					0.00%	0.00%	-0.26%	-0.26%	-0.25%	0.00%	-0.04%	-0.03%	-0.18%	-0.57%	-0.95%